Ostatné · ZTS
Zoetis Inc.
Fundamenty firmy Healthcare · Drug Manufacturers - Specialty & Generic · United States
Hodnotenie 0–10, vypočítané z údajov firmy
Analytici 14 hodnotení
nákup
- Najnižší cieľ
- 80,00
- Priemerný cieľ
- 96,00
- Najvyšší cieľ
- 155,00
- Potenciál
- +35,5 %
Odhad zisku na akciu (EPS)
| Obdobie | Odhad | Rozpätie | Pred rokom | Rast |
|---|---|---|---|---|
| tento štvrťrok | 1,51 | 1,46–1,61 | 1,70 | −10,9 % |
| budúci štvrťrok | 1,30 | 1,23–1,36 | 1,48 | −12,4 % |
| tento rok | 6,21 | 6,18–6,26 | 6,41 | −3,1 % |
| budúci rok | 6,54 | 6,08–7,62 | 6,21 | +5,4 % |
Odhad tržieb
| Obdobie | Odhad | Pred rokom | Rast |
|---|---|---|---|
| tento štvrťrok | 2,3 mld. | 2,4 mld. | −4,2 % |
| budúci štvrťrok | 2,2 mld. | 2,4 mld. | −6,9 % |
| tento rok | 9,2 mld. | 9,5 mld. | −2,4 % |
| budúci rok | 9,5 mld. | 9,2 mld. | +2,6 % |
Nákupy a predaje manažérov insider
| Kto | Čo | Hodnota | Dátum |
|---|---|---|---|
| D Amelio Frank ADirector | dar akcií | – | 07.08. |
| Mccallister Michael BDirector | dar akcií | – | 10.06. |
| Stetter MarkDirector | iná transakcia | – | 21.05. |
| Parent Louise MDirector | iná transakcia | – | 20.05. |
| Bisaro Paul M.Director | nákup | 151 750 | 13.05. |
| D Amelio Frank ADirector | nákup | 501 344 | 13.05. |
| Mccallister Michael BDirector | nákup | 233 273 | 11.05. |
| Esch Kevin Ph.d.Officer | iná transakcia | – | 30.04. |
| Sarbaugh KeithOfficer | iná transakcia | – | 31.03. |
| Norden GregoryDirector | dar akcií | – | 09.03. |
| D Amelio Frank ADirector | uplatnenie opcií | 206 109 | 19.02. |
| Khosla SanjayDirector | uplatnenie opcií | 206 109 | 19.02. |
Kto vlastní akcie
Blackrock Inc.9,54 %
Vanguard Capital Management LLC6,30 %
Vanguard Portfolio Management LLC5,77 %
State Street Corporation4,76 %
State Farm Mutual Automobile Insurance Co3,85 %
Geode Capital Management, LLC3,22 %
Wellington Management Group, LLP2,28 %
Morgan Stanley2,15 %
O firme (popis z Yahoo Finance, anglicky)
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep. It also offers parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics. In addition, the company provides animal health diagnostics, including point-of-care diagnostic products, instruments and reagents, rapid immunoassay tests, reference laboratory kits and services, and blood glucose monitors; and other non-pharmaceutical products, which include nutritionals, as well as products and services in biodevices, genetic tests, and precision animal health. It markets its products to veterinarians, livestock producers, and pet owners. The company has collaborated with Blacksmith Medicines, Inc. to discover and develop novel antibiotics for animal health. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Názor AI
Krátke zhodnotenie trendu, správ a blížiacich sa udalostí.
Technické signály
- Klesajúci trend – Kurz pod SMA50 aj SMA200
Odporúčania
K tomuto aktívu zatiaľ nemáme odporúčanie.
Predikcie
Žiadne predikcie.
Súvisiace správy
Žiadne správy so značkou ZTS.